Pre-exposure Prophylaxis Clinical Trials in Washington D.C., District of Columbia
2 recruitingWashington D.C., District of Columbia
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting
Predictors of Health Service Utilizations Among Key Population in Washington DC
Health BehaviorHIVPre-exposure Prophylaxis
Us Helping Us, People Into Living, Inc.100 enrolled1 locationNCT06046079